When your hospital loses DSH status, the 340B Orphan Drug Exclusion kicks in—and those deep discounts on high-cost specialty drugs? Gone. But there's a critical exception that most hospitals don't know about. This webinar shows you exactly what it is—and how to protect your savings.
$200K+
Average Annual Savings at Risk
90%
of Hospitals Don't Know the Exception
2015
The Rule That Changes Everything

We provide a safe, nurturing, and engaging environment where children feel valued and supported every day. Our staff ensures your child’s social, emotional, and educational growth.

Healthy bodies fuel healthy minds. We serve freshly prepared, balanced meals and snacks designed to meet children’s nutritional needs and encourage lifelong healthy eating habits.

Hands-on activities, creative play, and guided exploration help children learn by doing. We encourage curiosity, imagination, and problem-solving through structured and free play.

Your DSH hospital is facing eligibility loss and you don't know what happens to your orphan drug access
You've recently converted from DSH to RRC status and need clarity on the orphan drug exclusion
You've been told "orphan drugs don't apply to us anymore" —and want to verify that's actually true
You're a CFO, Pharmacy Director, or 340B Coordinator looking to protect every dollar of 340B savings
You want to understand the financial impact before your eligibility status changes
The 2015 Orphan Drug Ruling Decoded: Why the exclusion you think will apply to you probably won't—and what that means for your bottom line
The DSH-to-RRC Transition Trap: Exactly how losing DSH status changes your orphan drug access—and the hidden opportunity most hospitals miss entirely
Real Hospital Case Studies: See how facilities like yours recovered six figures in orphan drug savings they thought were gone forever
The Exception That Changes Everything: The specific provision that could save your orphan drug discounts even after you lose DSH status
Your 30-Day Action Plan: A concrete roadmap to assess your situation and protect your savings before it's too late


This is not a sales pitch. This is a real conversation.
Join me for a candid sit-down interview with Flaviu Simihaian, Co-Founder of Aventi Health — the only founder-owned 340B TPA in the country. Flaviu will walk us through how Aventi was built differently, who it was built for, and why small hospitals and FQHCs are at the center of everything they do.
You’ll get:
A live platform demo — see Aventi’s technology in action, built for simplicity and speed
A frank discussion on 340B TPA pricing — why most models are designed against small hospitals — and what Aventi does differently
Real talk about customer service — what it actually means to have direct access to the founders
Live Q&A — bring your toughest questions — Flaviu will answer them on air
Insight into onboarding timelines — how fast can you actually get up and running?
Your Host
PharmD, BCPS
Founder and CEO of 340B Orphan Drug Solutions, an independent consulting firm with 40+ years in healthcare and more than 11 years of specialized expertise in 340B orphan drug optimization for expansion entities.
Lisa has spent her career helping Critical Access Hospitals, Sole Community Hospitals, and Rural Referral Centers unlock $200,000 to $400,000+ in annual uncaptured 340B savings — savings most expansion entities don’t even know they’re leaving on the table.
In this webinar, Lisa brings her signature no-nonsense interview style to ask the questions you’ve been afraid to ask your current TPA.

If you want the live demo and unfiltered Q&A you must be there live.
May 14 • 1:00PM Eastern Seats Are Limited — Register Today

© 2026 340B Orphan Drug Solutions. All rights reserved.